The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
Social media is spotlighting GLP-1 receptor agonist side effects that clinical trials overlooked, according to a new study in Nature Health. Researchers sifted through 410,198 Reddit posts on semaglutide and tirzepatide, finding 43.5% of users reporting issues like nausea and fatigue. These insights reveal patient concerns beyond traditional data.
Content creator Aishwarya Mohanraj's candid video about dropping from 74kg to 52kg in six months on Mounjaro has spotlighted the injectable drug. Amid PCOS and hypothyroidism challenges, her story shifts focus from Ozempic hype. But experts warn: pair it with lifestyle changes or risk weight regain.
The hype around Mounjaro's weight loss results is real, but so is 'Mounjaro face'—sharper yet tired-looking facial changes from rapid fat loss. Dermatologists and surgeons report more patients with hollowed cheeks and sagging skin seeking help. Experts reveal why it occurs and essential prevention strategies focusing on nutrition and skincare.
With semaglutide's patent expired in India, over 50 generic brands are flooding the market at competitive prices, fueling a five-fold GLP-1 expansion to ₹5,000 crore by 2030. Startups like HealthifyRx, VLCC, Sugarfit, and FITPASS are redefining weight loss with holistic programs combining drugs, coaching, and muscle preservation. Investors warn that only comprehensive care models will thrive amid rising competition.
With GLP-1 drugs like semaglutide booming in India, dietitian Deepta Nagpall shares her exact daily meal plan to ensure adequate protein and fibre despite suppressed appetite. From omelettes to Greek yogurt, these nutrient-dense choices combat muscle loss and indigestion. Build sustainable habits for long-term success on weight loss medications.
A 32-year-old bride-to-be turned to Wegovy for wedding weight loss, only to face black tongue, unbearable stomach pain, and gallbladder removal. Sarah-Jayne Crawford's ordeal highlights hidden dangers of semaglutide injections. Despite initial success, severe side effects led to emergency surgery.
Many patients start GLP-1 medications like Ozempic and Zepbound for obesity but quit within a year, with fewer than one in four remaining on treatment. Shockingly, 74% of those who stop plan to restart, despite experts warning against this cycling approach. This guide explores the data, risks like muscle loss, and what it means for your health.
Elon Musk's dramatic before and after photos have gone viral, spotlighting his slimmer appearance after confirming Mounjaro use. The Tesla CEO's 'Ozempic Santa' post ignited speculation on GLP-1 drugs' role in his 30-pound weight loss. Understand the science behind 'Mounjaro face' and real transformations.
Why do some people lose remarkable weight on Ozempic while others see minimal results or severe nausea? A new Nature study of nearly 28,000 GLP-1 drug users shows your genes are a key factor. Specific variants in GLP1R and GIPR genes predict both efficacy and side effects, opening doors to personalized prescribing.
